ALCJ.PA实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:35):

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector...

Stats
今日成交量	57 012.00
平均成交量	113 984
市值	73.43M
EPS	€0 ( 2024-04-24 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-5.61
ATR14	€0.0100 (0.50%)

音量相关性

長: -0.24 (neutral)

短: -0.35 (neutral)

Signal:(46.964) Neutral

Crossject SA 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Crossject SA 相关性 - 货币/商品

0.65
( moderate )

0.29
( neutral )

0.00
( neutral )

0.58
( weak )

-0.14
( neutral )

Crossject SA 财务报表

Annual	2023
营收:	€145 000
毛利润:	€-18.35M (-12 657.24 %)
EPS:	€-0.240

FY	2023
营收:	€145 000
毛利润:	€-18.35M (-12 657.24 %)
EPS:	€-0.240

FY	2022
营收:	€954 000
毛利润:	€-13.89M (-1 456.39 %)
EPS:	€-0.310

FY	2021
营收:	€912 000
毛利润:	€-390 000 (-42.76 %)
EPS:	€-0.408

Financial Reports:

No articles found.

Crossject SA

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.